Blood & Plasma
This journal was formerly published as Plasmatology and continues under the new title Blood & Plasma.
Blood & Plasma is a peer-reviewed, gold open-access journal dedicated to advancing the science and clinical understanding of blood and plasma in human health and disease through an interdisciplinary lens. Our mission is to explore their central role in health, diseases, and therapeutics—fostering research that connects molecular biology, clinical practice, pathology, and public health.
Our goal is to publish novel research, even if it represents an incremental advance. While our primary focus is on ensuring sound scientific practices, including adherence to ethical standards and the use of robust, transparent, and reproducible methodologies, we recognise the value of incremental contributions to the field. We care more about the quality and reliability of the contribution an article makes than we do the size of that contribution. Blood & Plasma evaluates manuscripts based on how the research was conducted and reported.
Please see the Aims and Scope tab for further information.
Diversity, Equity and Inclusion statement
Blood & Plasma promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the research community.
Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.
We welcome editors, editorial board members, peer reviewers, and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status, or any other individual status.
We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.
Submission information
Submit your manuscript today at https://mc.manuscriptcentral.com/bdx
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Open access article processing charge (APC) information
The Article Processing Charge (APC) is $3000 USD, currently discounted to a rate of $1500.
Pre-submission queries
Pre-submission enquiries are welcome, including questions related to scope fit, article types, and study requirements.
Please direct pre-submission queries to Dr. Amy Goundry at amy.goundry@sagepub.co.uk.
For questions about a submitted paper or to request an extension for a review or revision, please contact the journal's editorial office at bdx@sagepub.com.
Blood & Plasma is a peer-reviewed, gold open-access journal dedicated to advancing the science and clinical understanding of blood and plasma in human health and disease through an interdisciplinary lens. Our mission is to explore their central role in health, diseases, and therapeutics—fostering research that connects molecular biology, clinical practice, pathology, and public health.
We welcome contributions that reflect the diverse and evolving landscape of blood and plasma research. Submissions may include preclinical, retrospective, prospective, observational, or clinical trial studies, as well as technically sound experimental and computational research, provided they demonstrate scientific rigor and appropriate validation. Blood & Plasma only considers in silico studies if they include robust external validation using an independent cohort or biological validation (in vitro or in vivo) and demonstrate potential clinical relevance.
The journal is especially interested in work that:
- Explores core biological properties of blood and plasma, including fluid dynamics, protein composition, cellular interactions, and their roles in maintaining homeostasis and responding to physiological stress.
- Recognizes blood as a dynamic system—not just a diagnostic medium, but a central player in immunity, inflammation, infection, and systemic disease.
- Examines molecular and cellular mechanisms, including RNA biology, iron metabolism, and immune modulation.
- Uses advanced histological and imaging methods to study blood, plasma, bone marrow, and lymphatic tissues at the structural and pathological level.
- Investigates hematologic manifestations of viral infections, blood-based diagnostics, and immune responses to emerging pathogens.
- Investigates hematologic disorders, such as anemia, hemoglobinopathies, coagulopathies, thrombocytopenia, leukemias, lymphomas, and myeloproliferative diseases.
- Focuses on diagnostic tools including biomarkers, liquid biopsies, and methods for tracking disease and treatment response.
- Explores intersections with immunology, oncology, cardiovascular medicine, infectious diseases, histopathology, and regenerative therapies including stem cell-based approaches.
- Advances transfusion medicine including innovations in blood collection, storage, compatibility testing, and strategies to optimize safety and efficacy in clinical practice.
- Develops blood products and plasma-derived therapies, focusing on novel manufacturing techniques, pathogen reduction technologies, and therapeutic applications for rare and common conditions.
- Supports population-level research, including epidemiology, disease burden, and outcomes across diverse clinical settings.
- Advances health equity in blood or plasma-related conditions, focusing on disparities in access, diagnosis, treatment, and long-term care.
Blood & Plasma is committed to publishing impactful, sound science that advances the field of blood and plasma and informs clinical and translational progress across disciplines. Authors are encouraged to clearly outline the clinical relevance or translational impact of their work.
| Amy Goundry, PhD | SAGE Publications Ltd, UK |
| Meera Shifa, BDS | SAGE Publishing, India |
| Huy Pham, MD, MPH | Be The Match Seattle Collection Center, USA |
| Zbigniew Szczepiorkowski, MD, PhD | Geisel School of Medicine at Dartmouth, USA |
| Christopher Tormey, MD | Yale New Haven Hospital, USA |
| Chester Andrzejewski, MD, PhD | Baystate Medical Center, USA |
| Vicente Arroyo, MD, PhD | European Foundation for the Study of Chronic Liver Failure, Spain |
| Mercè Boada, MD, PhD | Universitat Internacional de Catalunya, Spain |
| Joan Cid, MD, PhD | Hospital Clínic de Barcelona, Spain |
| Daniele Focosi, MD, PhD | Pisa University Hospital, Italy |
| Pietro Gentile, MD, PhD | University of Tor Vergata, Italy |
| Larry Gold, PhD | SomaLogic, Inc., Boulder, USA |
| Jerrold Levy, MD, FAHA | Duke University, USA |
| Freddy Nguyen, MD, PhD | Mount Sinai Hospital, USA |
| Resia Pretorius, PhD | Department Physiological Sciences, Stellenbosch University, South Africa |
| Agustin Ruiz, MD, PhD | Universitat Internacional de Catalunya, Spain |
| Elizabeth Staley, MD, PhD | The University of Alabama at Birmingham, USA |
| Claudia Stefanutti, MD, PhD | Sapienza Università di Roma, Italy |
| Rachel Thorpe, PhD | Australian Red Cross Lifeblood, Australia |
| Tony Wyss-Coray, PhD | Stanford University School of Medicine, USA |
| Mehmet Baysal, MD | Hematology Department, Tekirdag I. Fehmi Cumalioglu City Hospital, Türkiye |
| Olusola Olarewaju, MB ChB | Obafemi Awolowo University, Nigeria |
| Archit Pandharipande, DM | All India institute of medical sciences Nagpur, India |